AMERICAN INTERNATIONAL GROUP, INC. - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$869,000
+59.2%
46,060
-0.7%
0.00%
+100.0%
Q2 2019$546,000
+7.7%
46,382
+24.8%
0.00%0.0%
Q1 2019$507,000
+29.0%
37,152
-3.1%
0.00%0.0%
Q4 2018$393,000
-39.0%
38,356
-0.8%
0.00%0.0%
Q3 2018$644,000
+7.3%
38,651
+1.8%
0.00%0.0%
Q2 2018$600,000
+16.5%
37,955
-6.3%
0.00%0.0%
Q1 2018$515,000
+5.3%
40,525
-5.1%
0.00%0.0%
Q4 2017$489,000
-5.0%
42,704
+1.5%
0.00%0.0%
Q3 2017$515,000
+53.7%
42,060
+43.7%
0.00%
+100.0%
Q2 2017$335,000
-44.2%
29,276
+1.5%
0.00%
-50.0%
Q1 2017$600,000
+7.1%
28,849
+7.1%
0.00%0.0%
Q4 2016$560,000
-99.9%
26,939
-0.3%
0.00%
-50.0%
Q3 2016$885,085,000
+31.4%
27,009
+0.2%
0.00%
+33.3%
Q2 2016$673,391,000
+102.8%
26,968
+98.7%
0.00%
+200.0%
Q1 2016$332,000,000
-16.8%
13,574
+12.2%
0.00%
-50.0%
Q4 2015$399,000,000
+100403.8%
12,093
-0.2%
0.00%0.0%
Q3 2015$397,000
-99.9%
12,114
+0.1%
0.00%
-33.3%
Q2 2015$640,937,000
+341.4%
12,100
+140.5%
0.00%
+200.0%
Q1 2015$145,195,000
-0.8%
5,0310.0%0.00%0.0%
Q4 2014$146,352,000
+120.7%
5,031
-3.8%
0.00%
Q3 2014$66,304,000
-36.9%
5,229
-0.1%
0.00%
Q2 2014$105,026,0005,2330.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders